134 related articles for article (PubMed ID: 26137238)
1. mRNA overexpression of
Azizi Z; Rahgozar S; Moafi A; Dabaghi M; Nadimi M
Biomed Rep; 2015 May; 3(3):371-374. PubMed ID: 26137238
[No Abstract] [Full Text] [Related]
2. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
5. WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy.
Mehralizadeh H; Aliparasti MR; Talebi M; Salekzamani S; Almasi S; Raeisi M; Yousefi M; Movassaghpour A
Adv Pharm Bull; 2021 Jan; 11(1):197-203. PubMed ID: 33747867
[No Abstract] [Full Text] [Related]
6. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Significance of the BMI-1 and BAALC Genes in Adult Patients with Acute Myeloid Leukemia.
Shafik NF; El Ashry MS; Badawy RH; Hussein MM; Hassan NM
Indian J Hematol Blood Transfus; 2020 Oct; 36(4):652-660. PubMed ID: 33100707
[TBL] [Abstract][Full Text] [Related]
8. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667
[TBL] [Abstract][Full Text] [Related]
9. BAALC and ERG Expression in Egyptian Patients with Acute Myeloid Leukemia, Relation to Survival and Response to Treatment.
Soliman A; Aal AA; Afify R; Ibrahim N
Open Access Maced J Med Sci; 2016 Jun; 4(2):264-70. PubMed ID: 27335598
[TBL] [Abstract][Full Text] [Related]
10. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia.
Kühnl A; Gökbuget N; Stroux A; Burmeister T; Neumann M; Heesch S; Haferlach T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood; 2010 May; 115(18):3737-44. PubMed ID: 20065290
[TBL] [Abstract][Full Text] [Related]
11. Role of BAALC Gene in Prognosis of Acute Lymphoblastic Leukemia in Egyptian Children.
Hagag AA; Elshehaby WA; Hablas NM; Abdelmageed MM; Abd El-Lateef AE
Indian J Hematol Blood Transfus; 2018 Jan; 34(1):54-61. PubMed ID: 29398800
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of brain and acute leukemia cytoplasmic gene expression in egyptian children with acute myeloid leukemia.
Hagag AA; El-Lateef AE
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015033. PubMed ID: 25960861
[TBL] [Abstract][Full Text] [Related]
13. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
14. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis.
Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L
Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438
[TBL] [Abstract][Full Text] [Related]
15. Low MDR1 and BAALC expression identifies a new subgroup of intermediate cytogenetic risk acute myeloid leukemia with a favorable outcome.
Guo X; Shi P; Chen F; Zha J; Liu B; Li R; Dong H; Zheng H; Xu B
Blood Cells Mol Dis; 2014 Sep; 53(3):144-8. PubMed ID: 24855032
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia.
Aref S; Al Khodary T; Zeed TA; El Sadiek A; El Menshawy N; Al Ashery R
Indian J Hematol Blood Transfus; 2015 Mar; 31(1):21-8. PubMed ID: 25548440
[TBL] [Abstract][Full Text] [Related]
17. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.
Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G
J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499
[TBL] [Abstract][Full Text] [Related]
18. Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Eisfeld AK; Marcucci G; Liyanarachchi S; Döhner K; Schwind S; Maharry K; Leffel B; Döhner H; Radmacher MD; Bloomfield CD; Tanner SM; de la Chapelle A
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6668-73. PubMed ID: 22493267
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of BAALC gene expression for detection of minimal residual disease and risk stratification in normal karyotype acute myeloid leukaemia.
Weber S; Haferlach T; Alpermann T; Perglerová K; Schnittger S; Haferlach C; Kern W
Br J Haematol; 2016 Dec; 175(5):904-916. PubMed ID: 27662611
[TBL] [Abstract][Full Text] [Related]
20. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
